Clinical Trial Update: Double-Blind, Randomized, Single Dose Escalation Safety Study of Intraarticular Bone Morphogenic Protein (38A BMP-7) in Subjects With Osteoarthritis (OA) of the Knee [Phase 1]

View source ↗

Summary

Phase 1 double-blind, randomized, single-dose safety study of intraarticular bone morphogenetic protein-7 (BMP-7) for osteoarthritis of the knee, sponsored by S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• BMP-7 (bone morphogenetic protein-7)

Snippet

Sponsor: Stryker Biotech | Conditions: Osteoarthritis of the Knee | Phase 1 | Status: COMPLETED